{"id":40062,"date":"1998-08-01T12:03:00","date_gmt":"1998-08-01T10:03:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1998\/vitamin-b-zur-prophylaxe-der-migraene"},"modified":"1998-08-01T12:03:00","modified_gmt":"1998-08-01T10:03:00","slug":"vitamin-b-zur-prophylaxe-der-migraene","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/","title":{"rendered":"Vitamin B zur Prophylaxe der Migr\u00e4ne?"},"content":{"rendered":"<p>Zur prophylaktischen Behandlung der Migr\u00e4ne werden Betarezeptoren-Blocker (z.B. Metoprolol = Beloc u.v.a., Propranolol = Dociton u.v.a.) als Medikamente erster Wahl eingesetzt. Ein ausreichender Wirksamkeitsnachweis aus Studien liegt dar\u00fcber hinaus f\u00fcr Valproins\u00e4ure (Convulex u.v.a.) vor. Auch andere Pharmaka sind prophylaktisch wirksam, z.B. die Serotoninantagonisten Pizotifen (Sandomigran) und Methysergid (Deseril) sowie der Kalziumantagonist Flunarizin (Sibelium u.a.). Die [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zur prophylaktischen Behandlung der Migr\u00e4ne werden Betarezeptoren-Blocker (z.B. Metoprolol = Beloc u.v.a., Propranolol = Dociton u.v.a.) als Medikamente erster Wahl eingesetzt. Ein ausreichender Wirksamkeitsnachweis aus Studien liegt dar\u00fcber hinaus f\u00fcr Valproins\u00e4ure (Convulex u.v.a.) vor. Auch andere Pharmaka sind prophylaktisch wirksam, z.B. die Serotoninantagonisten Pizotifen (Sandomigran) und Methysergid (Deseril) sowie der Kalziumantagonist Flunarizin (Sibelium u.a.). Die [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[5762,102,6490,7062],"class_list":["post-40062","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-melas-syndrom","tag-migraene","tag-riboflavin","tag-vitamin-b2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vitamin B zur Prophylaxe der Migr\u00e4ne? - Der Arzneimittelbrief<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vitamin B zur Prophylaxe der Migr\u00e4ne? - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"Zur prophylaktischen Behandlung der Migr\u00e4ne werden Betarezeptoren-Blocker (z.B. Metoprolol = Beloc u.v.a., Propranolol = Dociton u.v.a.) als Medikamente erster Wahl eingesetzt. Ein ausreichender Wirksamkeitsnachweis aus Studien liegt dar\u00fcber hinaus f\u00fcr Valproins\u00e4ure (Convulex u.v.a.) vor. Auch andere Pharmaka sind prophylaktisch wirksam, z.B. die Serotoninantagonisten Pizotifen (Sandomigran) und Methysergid (Deseril) sowie der Kalziumantagonist Flunarizin (Sibelium u.a.). Die [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"1998-08-01T10:03:00+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2012\/06\/logo_amb_neu.jpg\" \/>\n<meta name=\"author\" content=\"Dennis Hoppe\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dennis Hoppe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/vitamin-b-zur-prophylaxe-der-migraene\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/vitamin-b-zur-prophylaxe-der-migraene\\\/\"},\"author\":{\"name\":\"Dennis Hoppe\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"headline\":\"Vitamin B zur Prophylaxe der Migr\u00e4ne?\",\"datePublished\":\"1998-08-01T10:03:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/vitamin-b-zur-prophylaxe-der-migraene\\\/\"},\"wordCount\":588,\"keywords\":[\"MELAS-Syndrom\",\"Migr\u00e4ne\",\"Riboflavin\",\"Vitamin B2\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/vitamin-b-zur-prophylaxe-der-migraene\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/vitamin-b-zur-prophylaxe-der-migraene\\\/\",\"name\":\"Vitamin B zur Prophylaxe der Migr\u00e4ne? - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"datePublished\":\"1998-08-01T10:03:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/vitamin-b-zur-prophylaxe-der-migraene\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/vitamin-b-zur-prophylaxe-der-migraene\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/vitamin-b-zur-prophylaxe-der-migraene\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vitamin B zur Prophylaxe der Migr\u00e4ne?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\",\"name\":\"Dennis Hoppe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"caption\":\"Dennis Hoppe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vitamin B zur Prophylaxe der Migr\u00e4ne? - Der Arzneimittelbrief","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/","og_locale":"de_DE","og_type":"article","og_title":"Vitamin B zur Prophylaxe der Migr\u00e4ne? - Der Arzneimittelbrief","og_description":"Zur prophylaktischen Behandlung der Migr\u00e4ne werden Betarezeptoren-Blocker (z.B. Metoprolol = Beloc u.v.a., Propranolol = Dociton u.v.a.) als Medikamente erster Wahl eingesetzt. Ein ausreichender Wirksamkeitsnachweis aus Studien liegt dar\u00fcber hinaus f\u00fcr Valproins\u00e4ure (Convulex u.v.a.) vor. Auch andere Pharmaka sind prophylaktisch wirksam, z.B. die Serotoninantagonisten Pizotifen (Sandomigran) und Methysergid (Deseril) sowie der Kalziumantagonist Flunarizin (Sibelium u.a.). Die [&hellip;]","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"1998-08-01T10:03:00+00:00","og_image":[{"url":"http:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2012\/06\/logo_amb_neu.jpg","type":"","width":"","height":""}],"author":"Dennis Hoppe","twitter_misc":{"Verfasst von":"Dennis Hoppe","Gesch\u00e4tzte Lesezeit":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/"},"author":{"name":"Dennis Hoppe","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"headline":"Vitamin B zur Prophylaxe der Migr\u00e4ne?","datePublished":"1998-08-01T10:03:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/"},"wordCount":588,"keywords":["MELAS-Syndrom","Migr\u00e4ne","Riboflavin","Vitamin B2"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/","name":"Vitamin B zur Prophylaxe der Migr\u00e4ne? - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"datePublished":"1998-08-01T10:03:00+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/vitamin-b-zur-prophylaxe-der-migraene\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Vitamin B zur Prophylaxe der Migr\u00e4ne?"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16","name":"Dennis Hoppe","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","caption":"Dennis Hoppe"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/40062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=40062"}],"version-history":[{"count":0,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/40062\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=40062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=40062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=40062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}